Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8653069
APP PUB NO 20110160199A1
SERIAL NO

13056365

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention discloses an aralkyl substituted piperidine or piperazine derivative and the use of the derivative in preparation of medicaments for treating schizophrenia and correlative psychoneuroses. It is shown by pharmacological tests that the derivative of the present invention has better antischizophrenic effect and less toxicity. Said derivative is a free base or salt of the compound having the following general formula.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
JIANGSU HENGYI PHARMACEUTICAL CO LTDNANJING JIANGSU PROVINCE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cai, Wangping Nanjing, CN 4 6
Gao, Kai Nanjing, CN 40 62
Li, Jianqi Shanghai, CN 36 96
Peng, Shaoping Shanghai, CN 14 42

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 18, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00